Themis Bioscience
Employee Participants0
Total Rating0
Revenue$0
Developer of vaccines to prevent tropical infections. The company's core lead technology, Themaxyn, is a novel, patent-protected vaccine platform, that will be used to create novel vaccines for emerging tropical and travelers' diseases, including dengue, chikungunya and yellow fever virus. Read More
Headquarters , Vienna, 1190, AUT
Website www.themisbio.com
0/100